Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Jaguar Animal Health ( (JAGX) ) has issued an update.
On January 6, 2026, Jaguar Health, Inc. entered into securities purchase agreements with two accredited investors and closed a financing in which it issued $350,000 in unsecured promissory notes bearing 6% annual interest and maturing one month after issuance, with proceeds allocated to working capital and other general corporate purposes. As part of the transaction, the investors also received warrants to purchase up to 350,000 shares of Jaguar’s common stock at an initial exercise price of $1.00 per share, exercisable immediately and expiring upon the earlier of five years, a fundamental transaction, or a liquidation event; the deal was executed as a private placement exempt from SEC registration, reinforcing the company’s near-term liquidity but also modestly increasing potential future equity dilution for existing shareholders.
The most recent analyst rating on (JAGX) stock is a Sell with a $0.93 price target. To see the full list of analyst forecasts on Jaguar Animal Health stock, see the JAGX Stock Forecast page.
Spark’s Take on JAGX Stock
According to Spark, TipRanks’ AI Analyst, JAGX is a Neutral.
The score is held down primarily by weak financial performance (large ongoing losses, high leverage, and significant cash burn) and a bearish technical setup (price below key moving averages with negative MACD). Corporate news is constructive on crofelemer, but potential dilution and the lack of profitability/positive cash flow keep the overall score low.
To see Spark’s full report on JAGX stock, click here.
More about Jaguar Animal Health
Jaguar Health, Inc. operates in the pharmaceutical/biotech sector and is focused on developing and commercializing prescription therapies, with its capital-raising and financing activities aimed at supporting ongoing operations and general corporate purposes.
Average Trading Volume: 208,131
Technical Sentiment Signal: Sell
Current Market Cap: $4.03M
For a thorough assessment of JAGX stock, go to TipRanks’ Stock Analysis page.